tiprankstipranks
Century Therapeutics, Inc. (IPSC)
:IPSC
US Market

Century Therapeutics (IPSC) Income Statement

Compare
166 Followers

Century Therapeutics Income Statement

Last quarter (Q3 2024), Century Therapeutics's total revenue was $791.00K, an increase of 434.46% from the same quarter last year. In Q3, Century Therapeutics's net income was $-31.23M. See Century Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 2.23M$ 5.20M$ 0.00$ 0.00$ 0.00
Gross Profit
$ -10.81M$ -4.87M$ -4.58M$ -1.75M$ -249.00K
Operating Expenses
$ 148.78M$ 139.03M$ 94.88M$ 49.18M$ 20.03M
Depreciation and Amortization
$ 13.04M$ 10.07M$ 4.58M$ 1.75M$ 249.00K
EBITDA
$ -121.21M$ -119.34M$ -89.92M$ -51.44M$ -19.78M
Operating Income
$ -146.55M$ -133.83M$ -94.88M$ -53.90M$ -245.98M
Other Income/Expenses
$ 11.75M$ 2.99M$ -898.00K$ 323.00K$ 1.21M
Pretax Income
$ -134.79M$ -130.84M$ -95.78M$ -53.58M$ -244.77M
Net Income
$ -136.67M$ -130.93M$ -95.82M$ -54.66M$ -245.98M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -2.30$ -2.27$ -1.74$ -1.00$ -4.49
Diluted EPS
$ -2.30$ -2.27$ -1.74$ -1.00$ -4.49
Weighted Average Shares Outstanding
59.31M 57.76M 55.01M 54.82M 54.82M
Weighted Average Shares Outstanding (Diluted)
59.31M 57.76M 55.01M 54.82M 54.82M
Currency in USD

Century Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis